Compile Data Set for Download or QSAR
maximum 50k data
Found 430 with Last Name = 'song' and Initial = 'a'
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM50001885((risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-...)
Affinity DataKi:  0.880nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129721(US8802672, 11)
Affinity DataKi: <1nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129720(US8802672, 10)
Affinity DataKi: <1nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129716(US8802672, 1)
Affinity DataKi: <1nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129718(US8802672, 6)
Affinity DataKi:  2nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129717(US8802672, 2)
Affinity DataKi:  2nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129719(US8802672, 7)
Affinity DataKi:  2nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM6775(US8802672, 8)
Affinity DataKi:  2nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM129720(US8802672, 10)
Affinity DataKi:  10nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM129721(US8802672, 11)
Affinity DataKi:  10nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM129719(US8802672, 7)
Affinity DataKi:  10nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM50001885((risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-...)
Affinity DataKi:  13nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM50001885((risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-...)
Affinity DataKi:  13nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM35254(2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3...)
Affinity DataKi:  25.1nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM129718(US8802672, 6)
Affinity DataKi:  35nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM129717(US8802672, 2)
Affinity DataKi:  35nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM129716(US8802672, 1)
Affinity DataKi:  35nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM6775(US8802672, 8)
Affinity DataKi:  35nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(3) dopamine receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM35254(2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3...)
Affinity DataKi:  76nMAssay Description:Binding assays were carried out on rat recombinant D3 receptors (Perkin-Elmer, Cat. No. 6110139) expressed in Sf9 cells using [3H]spiperone (0.44-1.4...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Richter Gedeon

US Patent
LigandPNGBDBM35254(2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3...)
Affinity DataKi:  96nMAssay Description:D2 receptor binding was determined as described by Creese et al. (Eur. J. Pharmacol., 60:55-66, 1979) on rat brain striatal membrane preparation usin...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129718(US8802672, 6)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129720(US8802672, 10)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129721(US8802672, 11)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM6775(US8802672, 8)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129717(US8802672, 2)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129716(US8802672, 1)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-1A adrenergic receptor(Rattus norvegicus (Rat))
Richter Gedeon

US Patent
LigandPNGBDBM129719(US8802672, 7)
Affinity DataKi: >1.00E+3nMAssay Description:Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057581(4-(4-Fluoro-5-phenyl-3-trifluoromethyl-pyrazol-1-y...)
Affinity DataIC50:  1.70nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057618(4-[5-(3-Methyl-4-methylsulfanyl-phenyl)-3-trifluor...)
Affinity DataIC50:  3.70nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Chosun University

Curated by ChEMBL
LigandPNGBDBM50066953(CHEMBL3403240)
Affinity DataIC50:  4nMAssay Description:Inhibition of 15-PGDH (unknown origin) by fluorescence spectrophotometryMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarbonic anhydrase 9(Homo sapiens (Human))
Zhengzhou University

Curated by ChEMBL
LigandPNGBDBM50546171(CHEMBL4790443)
Affinity DataIC50:  4.20nMAssay Description:Inhibition of recombinant human CA9 preincubated for 15 mins by phenol red dye based stopped flow CO2 hydration assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057551(4-[5-(4-Dimethylamino-phenyl)-3-trifluoromethyl-py...)
Affinity DataIC50:  4.70nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 1(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057554(1,5-Bis-(4-methoxy-phenyl)-3-trifluoromethyl-1H-py...)
Affinity DataIC50:  5nMAssay Description:In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057606(4-[4-Chloro-5-(4-chloro-phenyl)-3-trifluoromethyl-...)
Affinity DataIC50:  5.30nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057575(4-[5-(4-Dimethylamino-3-fluoro-phenyl)-3-trifluoro...)
Affinity DataIC50:  5.70nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057609(4-[2-(4-Methoxy-phenyl)-5-trifluoromethyl-2H-pyraz...)
Affinity DataIC50:  6.70nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 1(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM13065(5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluor...)
Affinity DataIC50:  7nMAssay Description:In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057589(4-[5-(4-Methoxy-phenyl)-3-trifluoromethyl-pyrazol-...)
Affinity DataIC50:  8nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057591(4-[5-(4-Methylsulfanyl-phenyl)-3-trifluoromethyl-p...)
Affinity DataIC50:  9nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057620(4-[5-(4-Methoxy-3-methyl-phenyl)-3-trifluoromethyl...)
Affinity DataIC50:  9.30nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057610(4-[5-(4-Chloro-phenyl)-3-difluoromethyl-pyrazol-1-...)
Affinity DataIC50:  10nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Poniard Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50480563(CHEMBL561448)
Affinity DataIC50:  10nMAssay Description:Inhibition of HSP90 in human SKBR3 cells assessed as induction of Her2 degradationMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057527(4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyraz...)
Affinity DataIC50:  10nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057572(4-[4-Chloro-5-(4-chloro-phenyl)-3-cyano-pyrazol-1-...)
Affinity DataIC50:  10nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057602(4-[2-(4-Fluoro-phenyl)-5-trifluoromethyl-2H-pyrazo...)
Affinity DataIC50:  10nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Dalian Medical University

Curated by ChEMBL
LigandPNGBDBM5447(CHEMBL939 | GEFITINIB | Iressa | N-(3-Chloro-4-flu...)
Affinity DataIC50:  11nMAssay Description:Inhibition of recombinant wild type human EGFR (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assayMore data for this Ligand-Target Pair
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057552(4-[5-(5-Bromo-thiophen-2-yl)-3-trifluoromethyl-pyr...)
Affinity DataIC50:  12nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057608(4-(3-Difluoromethyl-5-p-tolyl-pyrazol-1-yl)-benzen...)
Affinity DataIC50:  13nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057560(4-[5-(3,4-Dichloro-phenyl)-3-trifluoromethyl-pyraz...)
Affinity DataIC50:  15nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Searle Research And Development

Curated by ChEMBL
LigandPNGBDBM50057562(4-[3-Difluoromethyl-5-(4-methoxy-phenyl)-pyrazol-1...)
Affinity DataIC50:  15nMAssay Description:In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 430 total ) | Next | Last >>
Jump to: